The Food and Drug Administration and IBM Watson Health are forming a partnership to investigate potential ways that blockchain technology can be used in healthcare.
The agency and IBM subsidiary have signed a two-year agreement that will enable them to jointly explore ways to use the emerging technology. Initial efforts will focus on oncology-related data.
Register or login for access to this item and much more
All Digital Insurance content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access